{"hands_on_practices": [{"introduction": "Managing Urea Cycle Disorders critically relies on diverting nitrogen away from the urea cycle into excretable molecules. This practice explores the quantitative basis of one such 'nitrogen-scavenging' therapy using sodium phenylbutyrate. By applying fundamental stoichiometric principles, you will calculate the amount of nitrogen removed based on a standard dose, providing a tangible link between pharmacology and metabolic outcome. [@problem_id:5215156]", "problem": "A newborn with suspected Urea Cycle Disorders (UCD) is initiated on nitrogen-scavenging therapy with sodium phenylbutyrate. In the hepatocyte, sodium phenylbutyrate is converted to phenylacetate, which conjugates with glutamine to form phenylacetylglutamine (PAGN). Assume complete biotransformation with a $1{:}1$ molar stoichiometry from administered sodium phenylbutyrate to PAGN under steady-state conditions. Each mole of PAGN carries two moles of nitrogen atoms derived from glutamine, thereby facilitating nitrogen excretion independent of the urea cycle.\n\nStarting from the law of conservation of matter and the definition of the mole, treat the administered mass of sodium phenylbutyrate per kilogram body weight as the input, and use the relationship between mass and amount of substance to determine the amount of PAGN formed. The dosing is $250\\ \\mathrm{mg/kg}$ of sodium phenylbutyrate, and the molecular weight of sodium phenylbutyrate is $186\\ \\mathrm{g/mol}$. Compute:\n\n1. The moles of phenylacetylglutamine formed per kilogram.\n2. The moles of nitrogen removed per kilogram, given that there are $2$ nitrogen atoms per mole of PAGN.\n\nRound your numerical results to four significant figures. Express both quantities in moles per kilogram. Provide your final answer as two numbers in a single row, with the first entry being the moles of phenylacetylglutamine per kilogram and the second entry being the moles of nitrogen per kilogram.", "solution": "The problem will be validated by first extracting the given information and then assessing its scientific grounding, consistency, and completeness.\n\n### Step 1: Extract Givens\n- **Drug and Dose**: The administered substance is sodium phenylbutyrate at a dose of $250\\ \\mathrm{mg/kg}$.\n- **Molecular Weight**: The molecular weight of sodium phenylbutyrate ($M_{\\text{NaPB}}$) is $186\\ \\mathrm{g/mol}$.\n- **Biochemical Pathway**: Sodium phenylbutyrate is converted to phenylacetate, which then conjugates with glutamine to form phenylacetylglutamine (PAGN).\n- **Stoichiometric Assumption 1**: The biotransformation from administered sodium phenylbutyrate to PAGN is assumed to be complete.\n- **Stoichiometric Assumption 2**: The molar stoichiometry between sodium phenylbutyrate and PAGN is $1{:}1$.\n- **Nitrogen Excretion**: Each mole of PAGN formed removes two moles of nitrogen atoms.\n- **Required Computations**:\n  1. The moles of phenylacetylglutamine (PAGN) formed per kilogram of body weight.\n  2. The moles of nitrogen removed per kilogram of body weight.\n- **Rounding**: Numerical results must be rounded to four significant figures.\n\n### Step 2: Validate Using Extracted Givens\n- **Scientific Grounding**: The problem is scientifically grounded. The described pathway for sodium phenylbutyrate is a well-established pharmacological mechanism for treating urea cycle disorders. Phenylacetate, the active metabolite, conjugates with glutamine. Glutamine ($\\text{C}_5\\text{H}_{10}\\text{N}_2\\text{O}_3$) contains two nitrogen atoms, so the formation of phenylacetylglutamine indeed sequesters two nitrogen atoms per molecule. The provided molecular weight for sodium phenylbutyrate is correct. The problem rests on fundamental principles of chemistry (stoichiometry) and pharmacology.\n- **Well-Posed**: The problem is well-posed. The a priori assumptions of complete biotransformation and $1{:}1$ molar stoichiometry, while idealizations of a complex biological system, render the problem uniquely solvable. All necessary data (dose, molecular weight, stoichiometry) are provided.\n- **Objectivity**: The problem is stated in objective, quantitative terms, free from bias or subjective claims.\n\n### Step 3: Verdict and Action\nThe problem is valid as it is scientifically sound, self-contained, and well-posed. The solution process will now proceed.\n\n### Solution Derivation\nThe solution is derived from the fundamental relationship between mass, amount of substance (moles), and molecular weight, in accordance with the law of conservation of matter as applied to chemical reactions (stoichiometry).\n\nLet $D_{\\text{mass}}$ be the administered mass of sodium phenylbutyrate per kilogram of body weight.\n$$D_{\\text{mass}} = 250\\ \\mathrm{mg/kg}$$\nLet $M_{\\text{NaPB}}$ be the molar mass (molecular weight) of sodium phenylbutyrate.\n$$M_{\\text{NaPB}} = 186\\ \\mathrm{g/mol}$$\n\nTo perform stoichiometric calculations, the mass must be in units consistent with the molar mass. We convert the dose from milligrams to grams.\n$$D_{\\text{mass}} = 250\\ \\mathrm{mg/kg} \\times \\frac{1\\ \\mathrm{g}}{1000\\ \\mathrm{mg}} = 0.250\\ \\mathrm{g/kg}$$\n\nThe amount of substance (moles) of sodium phenylbutyrate administered per kilogram, denoted as $n_{\\text{NaPB}}$, is calculated by dividing the mass per kilogram by the molar mass:\n$$n_{\\text{NaPB}} = \\frac{D_{\\text{mass}}}{M_{\\text{NaPB}}} = \\frac{0.250\\ \\mathrm{g/kg}}{186\\ \\mathrm{g/mol}}$$\n$$n_{\\text{NaPB}} \\approx 0.001344086\\ \\mathrm{mol/kg}$$\n\n**1. Moles of phenylacetylglutamine (PAGN) formed per kilogram**\n\nThe problem states that there is a $1{:}1$ molar stoichiometry for the conversion of sodium phenylbutyrate to PAGN under the assumption of complete transformation. Let $n_{\\text{PAGN}}$ be the moles of PAGN formed per kilogram.\n$$n_{\\text{PAGN}} = n_{\\text{NaPB}} \\times \\frac{1\\ \\text{mol PAGN}}{1\\ \\text{mol NaPB}}$$\n$$n_{\\text{PAGN}} = n_{\\text{NaPB}} \\approx 0.001344086\\ \\mathrm{mol/kg}$$\nRounding this result to four significant figures gives:\n$$n_{\\text{PAGN}} \\approx 0.001344\\ \\mathrm{mol/kg}$$\n\n**2. Moles of nitrogen removed per kilogram**\n\nThe problem states that each mole of PAGN carries away two moles of nitrogen atoms. Let $n_{\\text{N}}$ be the moles of nitrogen removed per kilogram. The relationship is:\n$$n_{\\text{N}} = n_{\\text{PAGN}} \\times \\frac{2\\ \\text{mol N}}{1\\ \\text{mol PAGN}}$$\n$$n_{\\text{N}} = 2 \\times n_{\\text{PAGN}} = 2 \\times \\frac{0.250\\ \\mathrm{g/kg}}{186\\ \\mathrm{g/mol}}$$\n$$n_{\\text{N}} \\approx 2 \\times 0.001344086\\ \\mathrm{mol/kg} \\approx 0.002688172\\ \\mathrm{mol/kg}$$\nRounding this result to four significant figures gives:\n$$n_{\\text{N}} \\approx 0.002688\\ \\mathrm{mol/kg}$$\n\nThe final answers are the moles of PAGN per kilogram and the moles of nitrogen per kilogram, rounded to four significant figures.", "answer": "$$\\boxed{\\begin{pmatrix} 0.001344 & 0.002688 \\end{pmatrix}}$$", "id": "5215156"}, {"introduction": "Beyond managing nitrogen, diagnosing the specific enzyme defect in a UCD often involves interpreting unique metabolic signatures. This exercise delves into the pathophysiology of Ornithine Transcarbamylase (OTC) deficiency, the most common UCD. You will model how the blockage at OTC shunts excess carbamoyl phosphate into the pyrimidine pathway, quantitatively predicting the resulting increase in urinary orotic acid, a hallmark diagnostic finding. [@problem_id:5215182]", "problem": "A six-month-old infant with suspected ornithine transcarbamylase (OTC) deficiency presents with hyperammonemia and markedly elevated urinary orotic acid. In the hepatocyte mitochondrion, carbamoyl phosphate synthetase 1 (CPS1) generates carbamoyl phosphate at a measured steady-state flux of $J_{\\mathrm{CPS1}} = 6.0$ $\\mathrm{mmol \\, day^{-1}}$. Under healthy steady-state, flux through OTC matches flux through CPS1. In OTC deficiency, the effective OTC flux is reduced by $0.80$ (that is, to $0.20$ of baseline), while CPS1 flux remains constant at $J_{\\mathrm{CPS1}}$. Assume the following are true and scientifically justified by mass conservation and known pathway stoichiometry:\n\n- The excess mitochondrial carbamoyl phosphate not consumed by OTC accumulates and a fixed fraction $\\alpha = 0.70$ is transported or otherwise appears in the cytosol, where it enters de novo pyrimidine synthesis via aspartate transcarbamylase.\n- The de novo pyrimidine pathway converts one mole of carbamoyl phosphate to one mole of orotate prior to its conversion to uridine monophosphate (UMP), that is, the stoichiometric yield $Y_{\\mathrm{orotate}} = 1$ $\\mathrm{mol \\, orotate \\, mol^{-1} \\, carbamoyl \\, phosphate}$.\n- Cytosolic conversion capacity of orotate to UMP via orotate phosphoribosyltransferase (OPRT) and orotidine decarboxylase (ODC) are limited to $V_{\\mathrm{UMP}} = 1.50$ $\\mathrm{mmol \\, day^{-1}}$, and any orotate produced in excess of this capacity is not retained at steady-state and is quantitatively excreted in urine.\n- The baseline urinary orotic acid excretion unrelated to mitochondrial carbamoyl phosphate diversion is small and can be treated as a constant background; you are to predict the incremental change due to the diversion described above.\n\nUsing only mass balance and stoichiometric reasoning grounded in these assumptions, compute:\n1) the flux of excess carbamoyl phosphate diverted to cytosolic pyrimidine synthesis, $J_{\\mathrm{div}}$; and\n2) the predicted change in urinary orotic acid excretion, $\\Delta U$, both in $\\mathrm{mmol \\, day^{-1}}$.\n\nRound each of the two requested values to three significant figures. Express both final values in $\\mathrm{mmol \\, day^{-1}}$.", "solution": "The problem statement has been evaluated and is determined to be valid. The analysis is as follows:\n\n1.  **Givens Extraction**:\n    -   Steady-state flux of carbamoyl phosphate synthetase 1: $J_{\\mathrm{CPS1}} = 6.0 \\, \\mathrm{mmol \\, day^{-1}}$.\n    -   Reduction of effective ornithine transcarbamylase (OTC) flux: by a factor of $0.80$, resulting in a residual flux of $0.20$ of baseline.\n    -   Healthy steady-state OTC flux, $J_{\\mathrm{OTC, healthy}} = J_{\\mathrm{CPS1}}$.\n    -   Fraction of excess carbamoyl phosphate diverted to cytosol: $\\alpha = 0.70$.\n    -   Stoichiometric yield of orotate from carbamoyl phosphate: $Y_{\\mathrm{orotate}} = 1 \\, \\mathrm{mol \\, orotate \\, mol^{-1} \\, carbamoyl \\, phosphate}$.\n    -   Maximum rate of orotate conversion to UMP: $V_{\\mathrm{UMP}} = 1.50 \\, \\mathrm{mmol \\, day^{-1}}$.\n    -   Any orotate produced in excess of $V_{\\mathrm{UMP}}$ is quantitatively excreted.\n    -   The task is to compute the flux of diverted carbamoyl phosphate, $J_{\\mathrm{div}}$, and the change in urinary orotic acid excretion, $\\Delta U$.\n    -   Final values must be rounded to three significant figures.\n\n2.  **Validation**:\n    -   **Scientifically Grounded**: The problem describes the known biochemical consequences of ornithine transcarbamylase (OTC) deficiency, a classic urea cycle disorder. The shunting of excess mitochondrial carbamoyl phosphate into the cytosolic pyrimidine synthesis pathway, leading to orotic aciduria, is a core pathophysiological mechanism used in diagnosis. The problem is a valid application of metabolic flux analysis.\n    -   **Well-Posed**: The problem is self-contained, providing all necessary quantitative data and relationships (fluxes, fractional diversion, stoichiometric yield, and a rate limit) to compute the required values. A unique solution exists.\n    -   **Objective**: The problem is stated in precise, quantitative language, free of ambiguity or subjective claims.\n\nThe problem is valid as it is scientifically sound, well-posed, and objective. There are no violations of the specified criteria. A solution will now be derived using mass balance principles.\n\nThe solution proceeds by calculating the flux through each relevant step of the metabolic pathway.\n\nFirst, we establish the baseline flux in a healthy state. The problem states that under healthy steady-state, the flux through OTC, $J_{\\mathrm{OTC, healthy}}$, matches the flux through carbamoyl phosphate synthetase 1 (CPS1), $J_{\\mathrm{CPS1}}$.\n$$J_{\\mathrm{OTC, healthy}} = J_{\\mathrm{CPS1}} = 6.0 \\, \\mathrm{mmol \\, day^{-1}}$$\n\nNext, we calculate the reduced flux through OTC in the deficient state, $J_{\\mathrm{OTC, def}}$. The problem states the flux is reduced by $0.80$, which means it is $1 - 0.80 = 0.20$ of the healthy baseline.\n$$J_{\\mathrm{OTC, def}} = (1 - 0.80) \\times J_{\\mathrm{OTC, healthy}} = 0.20 \\times 6.0 \\, \\mathrm{mmol \\, day^{-1}} = 1.2 \\, \\mathrm{mmol \\, day^{-1}}$$\n\nAccording to the principle of mass conservation, the excess carbamoyl phosphate that accumulates in the mitochondrion, $J_{\\mathrm{excess}}$, is the difference between its rate of production by CPS1 and its rate of consumption by the deficient OTC. The CPS1 flux is given as constant.\n$$J_{\\mathrm{excess}} = J_{\\mathrm{CPS1}} - J_{\\mathrm{OTC, def}} = 6.0 \\, \\mathrm{mmol \\, day^{-1}} - 1.2 \\, \\mathrm{mmol \\, day^{-1}} = 4.8 \\, \\mathrm{mmol \\, day^{-1}}$$\n\nThe first value to be computed is the flux of excess carbamoyl phosphate diverted to cytosolic pyrimidine synthesis, $J_{\\mathrm{div}}$. This is a fixed fraction, $\\alpha = 0.70$, of the total excess carbamoyl phosphate.\n$$J_{\\mathrm{div}} = \\alpha \\times J_{\\mathrm{excess}} = 0.70 \\times 4.8 \\, \\mathrm{mmol \\, day^{-1}} = 3.36 \\, \\mathrm{mmol \\, day^{-1}}$$\nRounding to three significant figures, $J_{\\mathrm{div}}$ is $3.36 \\, \\mathrm{mmol \\, day^{-1}}$.\n\nThis diverted carbamoyl phosphate enters the de novo pyrimidine synthesis pathway. The flux of orotate production, $J_{\\mathrm{orotate}}$, is determined by the flux of its precursor, $J_{\\mathrm{div}}$, and the stoichiometric yield, $Y_{\\mathrm{orotate}}$.\n$$J_{\\mathrm{orotate}} = J_{\\mathrm{div}} \\times Y_{\\mathrm{orotate}} = 3.36 \\, \\mathrm{mmol \\, day^{-1}} \\times 1 = 3.36 \\, \\mathrm{mmol \\, day^{-1}}$$\n\nThe second value to compute is the change in urinary orotic acid excretion, $\\Delta U$. This is the amount of orotate produced that exceeds the cytosolic capacity for its conversion to uridine monophosphate (UMP), which is limited to $V_{\\mathrm{UMP}}$. The excess is quantitatively excreted.\n$$\\Delta U = J_{\\mathrm{orotate}} - V_{\\mathrm{UMP}}$$\nThis equation is valid because the production flux ($J_{\\mathrm{orotate}} = 3.36 \\, \\mathrm{mmol \\, day^{-1}}$) is greater than the metabolic capacity ($V_{\\mathrm{UMP}} = 1.50 \\, \\mathrm{mmol \\, day^{-1}}$).\n$$\\Delta U = 3.36 \\, \\mathrm{mmol \\, day^{-1}} - 1.50 \\, \\mathrm{mmol \\, day^{-1}} = 1.86 \\, \\mathrm{mmol \\, day^{-1}}$$\nRounding to three significant figures, $\\Delta U$ is $1.86 \\, \\mathrm{mmol \\, day^{-1}}$.\n\nThe two requested values are the flux of diverted carbamoyl phosphate, $J_{\\mathrm{div}}$, and the change in urinary orotic acid excretion, $\\Delta U$.\n1. $J_{\\mathrm{div}} = 3.36 \\, \\mathrm{mmol \\, day^{-1}}$\n2. $\\Delta U = 1.86 \\, \\mathrm{mmol \\, day^{-1}}$", "answer": "$$\\boxed{\\begin{pmatrix} 3.36 & 1.86 \\end{pmatrix}}$$", "id": "5215182"}, {"introduction": "Effective long-term management of UCDs requires a delicate balance: providing enough protein for growth without overwhelming the patient's limited nitrogen disposal capacity. This comprehensive exercise simulates the real-world clinical challenge of designing a safe diet. You will perform a detailed nitrogen balance calculation, integrating the effects of scavenger drugs, residual enzyme function, and growth requirements to determine a maximum allowable protein intake. [@problem_id:5215168]", "problem": "A $12\\ \\mathrm{kg}$ child has a distal urea cycle disorder (UCD), specifically a defect beyond the formation of argininosuccinate, and is receiving nitrogen-scavenging therapy. You are asked to derive the maximum allowable intact dietary protein prescription in $\\mathrm{g/kg/day}$ that meets indispensable amino acid needs while avoiding excess ammonia accumulation.\n\nUse the following scientifically grounded facts and parameters:\n- Distal UCDs limit hepatic urea formation but allow nitrogen excretion to be supported by both residual ureagenesis and alternative conjugation pathways.\n- Protein contains nitrogen at a mass fraction of $0.16$ (that is, $16\\%$ of protein mass is nitrogen).\n- An indispensable (essential) amino acid mixture is prescribed at $0.50\\ \\mathrm{g/kg/day}$, and for distal UCDs, free-base L-arginine supplementation is required at $0.150\\ \\mathrm{g/kg/day}$; assume the indispensable amino acid mixture has the same nitrogen mass fraction as mixed dietary protein, and the nitrogen mass fraction of L-arginine free base is $0.321$.\n- Sodium benzoate conjugates with glycine to form hippurate, removing $1$ nitrogen atom per mole of benzoate utilized. Sodium phenylbutyrate (NaPBA) is converted to phenylacetate, which conjugates with glutamine, removing $2$ nitrogen atoms per mole of phenylbutyrate utilized. The child receives sodium benzoate at $5\\ \\mathrm{mmol/kg/day}$ and sodium phenylbutyrate at $3\\ \\mathrm{mmol/kg/day}$.\n- Residual hepatic ureagenesis capacity is estimated at $2\\ \\mathrm{mmol\\ N/kg/day}$ in this distal UCD.\n- Obligatory non-urea nitrogen losses (for example, stool and skin) are $0.5\\ \\mathrm{mmol\\ N/kg/day}$.\n- A conservative growth target requires net nitrogen deposition of 30 mg N/kg/day.\n- The atomic mass of nitrogen is $M_{N} = 14.01\\ \\mathrm{g/mol}$.\n\nAssume steady-state nitrogen balance at the target growth rate and that total nitrogen intake from intact dietary protein plus prescribed amino acid supplements must be matched by the sum of nitrogen excretion capacity (residual ureagenesis and alternative conjugation pathways) and obligatory losses, plus the targeted deposition. Derive the maximum allowable intact dietary protein in $\\mathrm{g/kg/day}$. Round your final numeric answer to four significant figures and express the dose in $\\mathrm{g/kg/day}$.", "solution": "The problem requires the derivation of the maximum allowable intact dietary protein prescription for a child with a distal urea cycle disorder (UCD) based on a nitrogen balance model. The fundamental principle is that at steady state, the total nitrogen intake must be equal to the total nitrogen disposition, which includes all pathways of excretion and net deposition for growth. We can express this as an equation:\n$$N_{\\text{intake}} = N_{\\text{disposition}}$$\nAll quantities will be expressed in units of $\\mathrm{mmol/kg/day}$ for consistency.\n\nFirst, we calculate the total nitrogen disposition, $N_{\\text{disposition}}$. This is the sum of nitrogen removed by residual ureagenesis, nitrogen-scavenging drugs, obligatory non-urea losses, and nitrogen utilized for growth.\n\nThe given components of nitrogen disposition are:\n1.  Residual hepatic ureagenesis capacity, $N_{\\text{urea}} = 2\\ \\mathrm{mmol\\ N/kg/day}$.\n2.  Nitrogen removal via sodium benzoate. The dose is $5\\ \\mathrm{mmol/kg/day}$, and each mole conjugates with glycine, removing $1$ nitrogen atom. Thus, the nitrogen removed is $N_{\\text{benzoate}} = 5\\ \\mathrm{mmol/kg/day} \\times 1 = 5\\ \\mathrm{mmol\\ N/kg/day}$.\n3.  Nitrogen removal via sodium phenylbutyrate. The dose is $3\\ \\mathrm{mmol/kg/day}$, and each mole is converted to phenylacetate, which conjugates with glutamine, removing $2$ nitrogen atoms. Thus, the nitrogen removed is $N_{\\text{phenylbutyrate}} = 3\\ \\mathrm{mmol/kg/day} \\times 2 = 6\\ \\mathrm{mmol\\ N/kg/day}$.\n4.  Obligatory non-urea nitrogen losses, $N_{\\text{loss}} = 0.5\\ \\mathrm{mmol\\ N/kg/day}$.\n5.  Nitrogen deposition for growth, $N_{\\text{growth}}$. The target is given as $30\\ \\mathrm{mg\\ N/kg/day}$. We convert this from a mass basis to a molar basis using the atomic mass of nitrogen, $M_N = 14.01\\ \\mathrm{g/mol}$, which is equivalent to $14.01\\ \\mathrm{mg/mmol}$.\n$$N_{\\text{growth}} = \\frac{30\\ \\mathrm{mg\\ N/kg/day}}{14.01\\ \\mathrm{mg/mmol}} = \\frac{30}{14.01}\\ \\mathrm{mmol\\ N/kg/day}$$\n\nThe total nitrogen disposition is the sum of these components:\n$$N_{\\text{disposition}} = N_{\\text{urea}} + N_{\\text{benzoate}} + N_{\\text{phenylbutyrate}} + N_{\\text{loss}} + N_{\\text{growth}}$$\n$$N_{\\text{disposition}} = 2 + 5 + 6 + 0.5 + \\frac{30}{14.01} = 13.5 + \\frac{30}{14.01}\\ \\mathrm{mmol\\ N/kg/day}$$\n\nNext, we formulate an expression for the total nitrogen intake, $N_{\\text{intake}}$. This is the sum of nitrogen from all dietary sources: intact protein, the indispensable amino acid (IAA) mixture, and L-arginine supplementation. Let $P_{\\text{intact}}$ represent the unknown maximum allowable mass of intact dietary protein in $\\mathrm{g/kg/day}$.\n\n1.  Nitrogen from intact protein, $N_{P_{\\text{intact}}}$. The mass of nitrogen is $P_{\\text{intact}} \\times 0.16$. Converting to millimoles:\n$$N_{P_{\\text{intact}}} = \\frac{P_{\\text{intact}}\\ (\\mathrm{g/kg/day}) \\times 0.16}{14.01\\ \\mathrm{g/mol}} \\times 1000\\ \\mathrm{mmol/mol} = \\frac{160 \\cdot P_{\\text{intact}}}{14.01}\\ \\mathrm{mmol\\ N/kg/day}$$\n2.  Nitrogen from the IAA mixture, $N_{IAA}$. The prescription is $0.50\\ \\mathrm{g/kg/day}$ with a nitrogen mass fraction of $0.16$.\n$$N_{IAA} = \\frac{0.50\\ \\mathrm{g/kg/day} \\times 0.16}{14.01\\ \\mathrm{g/mol}} \\times 1000\\ \\mathrm{mmol/mol} = \\frac{80}{14.01}\\ \\mathrm{mmol\\ N/kg/day}$$\n3.  Nitrogen from L-arginine, $N_{\\text{Arg}}$. The prescription is $0.150\\ \\mathrm{g/kg/day}$ with a nitrogen mass fraction of $0.321$.\n$$N_{\\text{Arg}} = \\frac{0.150\\ \\mathrm{g/kg/day} \\times 0.321}{14.01\\ \\mathrm{g/mol}} \\times 1000\\ \\mathrm{mmol/mol} = \\frac{48.15}{14.01}\\ \\mathrm{mmol\\ N/kg/day}$$\n\nThe total nitrogen intake is the sum of these sources:\n$$N_{\\text{intake}} = N_{P_{\\text{intact}}} + N_{IAA} + N_{\\text{Arg}}$$\n$$N_{\\text{intake}} = \\frac{160 \\cdot P_{\\text{intact}}}{14.01} + \\frac{80}{14.01} + \\frac{48.15}{14.01} = \\frac{160 \\cdot P_{\\text{intact}} + 128.15}{14.01}\\ \\mathrm{mmol\\ N/kg/day}$$\n\nNow, we equate total intake and total disposition:\n$$N_{\\text{intake}} = N_{\\text{disposition}}$$\n$$\\frac{160 \\cdot P_{\\text{intact}} + 128.15}{14.01} = 13.5 + \\frac{30}{14.01}$$\nTo solve for $P_{\\text{intact}}$, we first multiply both sides by $14.01$:\n$$160 \\cdot P_{\\text{intact}} + 128.15 = 13.5 \\times 14.01 + 30$$\n$$160 \\cdot P_{\\text{intact}} + 128.15 = 189.135 + 30$$\n$$160 \\cdot P_{\\text{intact}} + 128.15 = 219.135$$\nNext, we isolate the term containing $P_{\\text{intact}}$:\n$$160 \\cdot P_{\\text{intact}} = 219.135 - 128.15$$\n$$160 \\cdot P_{\\text{intact}} = 90.985$$\nFinally, we solve for $P_{\\text{intact}}$:\n$$P_{\\text{intact}} = \\frac{90.985}{160} = 0.56865625\\ \\mathrm{g/kg/day}$$\nThe problem asks for the answer to be rounded to four significant figures.\n$$P_{\\text{intact}} \\approx 0.5687\\ \\mathrm{g/kg/day}$$\nThe child's mass of $12\\ \\mathrm{kg}$ is contextual information not required for the calculation, as the final answer is requested in units of $\\mathrm{g/kg/day}$.", "answer": "$$\n\\boxed{0.5687}\n$$", "id": "5215168"}]}